List of contributors
• Part I:
1. Entries A–Z
• Part II:
2. Medication adverse effects
3. Cardiovascular and renal medications
4. Medications to treat diabetes
5. Hormones and medications to treat endocrine and bone disorders
6. Gastrointestinal medications
7. Vitamins and minerals
8. Medication to treat asthma and allergies
9. Antimicrobial medications
10. Antiretroviral medications
11. Immunosuppressive medications
12. Oncology and hematology medications
13. Disease-modifying antirheumatic medications (DMARDs)
14. Medications to treat neurodegenerative diseases
15. Medications to treat epilepsy
16. Medications to treat headache and migraine
17. Medications to treat mental health and substance abuse disorders
Symptoms and signs in neurology and psychiatry typically present in the clinical context of other underlying conditions. When evaluating a patient, a physician may choose to review a diverse list of potential underlying diagnoses with the aid of the editor team's existing text: Neurological Differential Diagnosis: A Case-Based Approach. However, if the patient has a known pre-existing condition, the physician will need to consider a reverse approach - considering what complications of that condition may be associated with current symptoms. This book provides quick-reference, comprehensive, concise summaries of neurologic, psychiatric and medical diagnoses with a focus on neurologic and psychiatric implications of systemic disorders. A separate pharmacology section provides a consolidated review of potential neurologic and psychiatric adverse effects of medications. This book is an invaluable resource for a broad medical audience, from the medical student to the experienced consultant.
• All entries are listed alphabetically for quick look-up
• Diagnostic conditions follow a stereotyped order of presentation including epidemiology and demographics, highlights of each disorder, neurologic and psychiatric symptoms and signs, secondary complications, and potential neurologic or psychiatric complications of treatments
• A separate reference guide is provided focusing on the neurologic and psychiatric complications of medications treatments
• Alan B. Ettinger, Safe Passage Diagnostics, New YorkAlan B. Ettinger is the Medical Director at Safe Passage EEG Services based in New York. He is a former Professor in the Department of Clinical Neurology at the Albert Einstein College of Medicine, New York, and President of the Professional Advisory Board of the Epilepsy Foundation of Long Island.
• Deborah M. Weisbrot is a Clinical Professor of Psychiatry at the Medical Center of the State University of New York, Stony Brook and a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry. Dr Weisbrot's current clinical work is as a consulting psychiatrist for several therapeutic schools and she has researched and published widely on psychiatric comorbidities of neurological disorders. She lectures nationally in the US on the critical issue of school threat assessment.
• Casey E. Gallimore is an Associate Professor at the School of Pharmacy of the University of Wisconsin, Madison, which she joined in 2007 and where she currently teaches in the areas of mental health pharmacy and pharmaceutical care skills. Dr Gallimore practices one day per week at Access Community Health Centers in Madison where she works with primary care clinicians and the behavioral health team to provide psychiatric pharmacy services.